# Tempest Therapeutics, Inc.: Form 8-K, filed Sep 6, 2016

- Company: [Tempest Therapeutics, Inc.](/companies/tpst.md) (CIK 1544227)
- Form: 8-K
- Filed: 2016-09-06
- Accepted by EDGAR: Sep 6, 2016, 16:58 ET
- Period: 2016-09-06
- Accession: 0001104659-16-143247
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1544227/000110465916143247/a16-17964_18k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1544227/000110465916143247/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1544227/000110465916143247/a16-17964_18k.htm

Filed Sep 6, 2016.
Source: SEC EDGAR, the filing index for accession 0001104659-16-143247. Last ingested by Listed: Nov 15, 2026, 00:20 ET. No prices; not investment advice.
